Danone Q1 2026 slides: growth resilient despite currency headwinds

The key market read is that Danone is proving it can still print mid-single-digit underlying growth while absorbing a lot of exogenous noise, which should support a relative-value rerating versus slower-growing staples peers. The second-order issue is that FX is now the dominant headline drag, so investors may be underestimating how much earnings leverage reappears if the euro stabilizes or weakens into H2; that can matter more than incremental volume beats over the next 2-3 quarters.

The more interesting strategic signal is the portfolio tilt: management is shifting toward higher-velocity, health-positioned nutrition assets while pruning geographic and category friction. That should improve mix and pricing power over 12-24 months, but it also raises execution risk because integration and regulatory close timelines can create a gap between narrative and P&L, especially if U.S. competitive pressure persists and the EMEA recall lingers into the next reporting cycle.

Consensus appears to be focused on the near-term top-line resilience, but the overhang is that geopolitics and FX can mask whether organic demand is actually inflecting or just being protected by pricing. If the Middle East environment de-escalates and supply chain normalization follows, the bounce in reported sales can be sharp; if not, the market may start discounting a low-teens multiple on more stable but not accelerating growth. The contrarian setup is that the stock can work even without a big growth upgrade, simply on margin durability and a reduction in perceived operational risk once the recall and geopolitical disruptions fade.